埃弗罗利斯对接受脏移植患者功能的影响:系统性审查和剂量反应元分析
Takehiro Ohyama1, Shodai Yoshihiro2, Tomoyuki Fujikura3
1Department of Urology, Division of Renal Surgery and Transplantation, General and Transplant Surgery, Jichi Medical University, Shimotsuke-City, Tochigi, Japan; Scientific Research WorkS Peer Support Group (SRWS-PSG), Osaka, Japan.
Transplantation reviews (Orlando, Fla.)
|February 22, 2025
概括
在移植接受者中,从氨尿素抑制剂 (CNIs) 转换为Everolimus (EVL) 的最佳低度的确定仍然不清楚. 目前的证据表明不确定性很高,不支持常规的CNI-EVL切换.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 埃弗罗利斯 (Everolimus,简称EVL) 是一种用于移植后的免疫抑制剂.
- 从氨酸抑制剂 (CNIs) 转换为EVL的最佳低度尚未确定.
- 了解这些度对于有效的免疫抑制和患者的治疗结果至关重要.
研究的目的:
- 在脏移植接受者中,调查切换从CNI到EVL的最佳剂量低谷.
- 分析EVL最低水平与治疗反应,死亡率,中断和不良事件之间的关系.
- 评估CNI-EVL转换策略的有效性和安全性.
主要方法:
- 在2024年3月15日之前对电子数据库进行系统的文献搜索.
- 包括双盲或开放的随机对照试验,比较CNI-to-EVL切换与CNI延续.
- 随机效应,一个阶段的剂量效应元分析,限制立方线.
主要成果:
- 分析了9项涉及1872名参与者的研究.
- 关于最佳EVL低度及其对估计球过率 (eGFR) 的影响的证据高度不确定.
- 高度的不确定性也围绕着EVL水平与死亡率,中止和不良事件之间的关联.
结论:
- 由于高度不确定性,这次元分析无法确定最佳的EVL最低度.
- 目前的证据不支持从CNI到EVL的例行切换.
- 需要进一步的研究来确定最佳的CNI-EVL切换时间和EVL剂量策略.
相关概念视频
01:11Renal Failure: Dose Adjustments
56
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
56
01:17Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
01:15Drug Elimination by Renal Route: Tubular Secretion
2.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K